Literature DB >> 1201249

Ultrastructural studies of the bone marrow in sickle cell anaemia. II. The morphology of erythropoietic cells and their response to deoxygenation in vitro.

J A Grasso, A L Sullivan, L W Sullivan.   

Abstract

Electron microscopic studies of bone marrow aspirates obtained from patients with homozygous sickle cell anaemia (HbSS) were fixed immediately without attempts to deoxygenate the samples. Erythroblasts and normoblasts in these preparations were devoid of haemoglobin polymers or other indications of sickling. Furthermore, the nucleated erythroid cells from sickle-cell patients presented an ultrastructural morphology indistinguishable from that of identically-processed erythroid cells in marrow samples from normal human volunteers. This report presents a description of the ultrastructural features of pronormoblasts and normoblasts in normal and sickle-cell marrows and stresses the essentially normal appearance of nucleated erythroid elements in sickle cell anaemia. Exposure of sickle-cell marrow aspirates to nitrogen at 37 degrees C for 30 min resulted in haemoglobin polymerization in most erythrocytes and reticulocytes but only in 10-20% of the nucleated erythroid cells. Haemoglobin polymers in the form of intertwining fibre meshworks were observed in reticulocytes, orthochromatic and polychromatophilic normoblasts, but were absent in basophilic normoblasts and pronormoblasts. The results suggest that the concentration of haemoglobin in intramedullary normoblasts may be the limiting factor determining the predisposition of these cells to undergo sickling as well as the pattern of haemoglobin aggregation. Under the physiological conditions prevailing in the marrow, haemoglobin concentration in normoblasts may be insufficient to result in aggregation and polymerization.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1201249     DOI: 10.1111/j.1365-2141.1975.tb00869.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  5 in total

1.  Evidence for ineffective erythropoiesis in severe sickle cell disease.

Authors:  Catherine J Wu; Lakshamanan Krishnamurti; Jeffery L Kutok; Melinda Biernacki; Shelby Rogers; Wandi Zhang; Joseph H Antin; Jerome Ritz
Journal:  Blood       Date:  2005-08-09       Impact factor: 22.113

Review 2.  Gene Therapy with Hematopoietic Stem Cells: The Diseased Bone Marrow's Point of View.

Authors:  Marina Cavazzana; Jean-Antoine Ribeil; Chantal Lagresle-Peyrou; Isabelle André-Schmutz
Journal:  Stem Cells Dev       Date:  2016-10-16       Impact factor: 3.272

3.  Reduction of intramedullary apoptosis after stem cell transplantation in black african variant of pediatric sickle cell anemia.

Authors:  Antonella Isgrò; Pietro Sodani; Marco Marziali; Javid Gaziev; Daniela Fraboni; Katia Paciaroni; Cristiano Gallucci; Gioia De Angelis; Cecilia Alfieri; Michela Ribersani; Daniele Armiento; Andrea Roveda; Marco Andreani; Manuela Testi; Guido Lucarelli
Journal:  Mediterr J Hematol Infect Dis       Date:  2014-07-07       Impact factor: 2.576

Review 4.  Metabolic Reprogramming in Sickle Cell Diseases: Pathophysiology and Drug Discovery Opportunities.

Authors:  Dina Alramadhani; Anfal S Aljahdali; Osheiza Abdulmalik; B Daniel Pierce; Martin K Safo
Journal:  Int J Mol Sci       Date:  2022-07-04       Impact factor: 6.208

5.  Characterization of Hematopoiesis in Sickle Cell Disease by Prospective Isolation of Stem and Progenitor Cells.

Authors:  Seda S Tolu; Kai Wang; Zi Yan; Shouping Zhang; Karl Roberts; Andrew S Crouch; Gracy Sebastian; Mark Chaitowitz; Eric D Fornari; Evan M Schwechter; Joan Uehlinger; Deepa Manwani; Caterina P Minniti; Eric E Bouhassira
Journal:  Cells       Date:  2020-09-24       Impact factor: 6.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.